Subscribe

ENDRA Life Sciences Inc. (NDRA)

USD5.39 -0.15 (-2.71%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address 3600 Green Court 48105-1570
Ann Arbor, MI, US
CEO Alexander Y. Tokman
IPO 2017-06-30
CIK 1681682 ISIN US29273B5003

Explore sections of this company profile

Also trades on NASDAQ Capital Market · NDRA (USD) NASDAQ Capital Market · NDRAW (USD)
Description

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD5.39 -0.15 (-2.71%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
28.2K
Beta
-0.05
Float Shares
681.8K
Free Float %
90.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-12.02% +1.41% -21.09% +43.06% -18.55% +11.48% +55.86% -99.79% -99.99% -100.00% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (4 ratings, all time) Buy
Price Targets & DCF
Current price
5.39
DCF (Levered) 0.34 -93.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-50.59
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Diagnostics & Research: +7.9%
  • EPS growth Medical - Diagnostics & Research: +30.8%
    +12.9% Q1'26: +41.4% (vs Q1'25)
  • FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%
  • EBIT margin Medical - Diagnostics & Research: +9.6%
  • ROIC Medical - Diagnostics & Research: +5.2%
    -289.6% Q1'26: -459.7% (vs Q1'25)
  • Share dilution Medical - Diagnostics & Research: 0.0%
    -29.9% Q1'26: +115.1% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×
    -0.09× Q1'26: -0.05× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.11) × ERP
WACC = 89% × Ke + 11% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 5.39
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Revenue
est: 225.0K (-100.0%)
est: 700.0K (-100.0%)
est: 100.0K (-100.0%)
est: 100.0K (-100.0%)
est: 100.0K (-100.0%)
100.0K
100.0K – 100.0K
+0.0% YoY
100.0K
100.0K – 100.0K
+0.0% YoY
EBITDA
-11.01M
-12.94M
-9.78M
-10.77M
-5.61M
— – —
— – —
EBIT
-11.23M
-13.18M
-10.06M
-10.82M
-5.76M
— – —
— – —
Net Income
-11.23M
est: -11.00B (+99.9%)
-13.18M
est: -8.64B (+99.8%)
-10.06M
est: -3.63B (+99.7%)
-11.51M
est: -37.35M (+69.2%)
-7.03M
est: -5.19M (-35.5%)
-3.66M
-3.66M – -3.66M
+29.4% YoY
-3.15M
-3.15M – -3.15M
+14.0% YoY
SGA
5.79M
6.37M
5.24M
7.63M
3.91M
— – —
— – —
EPS
-5.47
est: -9,800.00 (+99.9%)
-4.57
est: -7,700.00 (+99.9%)
-5.89
est: -3,237.50 (+99.8%)
-10.25
est: -47.46 (+78.4%)
-8.93
est: -6.59 (-35.5%)
-4.65
-4.65 – -4.65
+29.4% YoY
-4.00
-4.00 – -4.00
+14.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-15 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-05-14 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-13 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-12 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-05-11 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-08 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-07 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-06 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-05 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-04 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-05-01 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-04-30 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-04-29 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-04-28 C 2/5 2/5 1/5 1/5 2/5 1/5 4/5
2026-04-27 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-04-24 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-04-23 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-7.40M
OE per share TTM
-6.78
Owner's Yield
-122.12%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
66,324.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
6
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 L1 Capital Global Opportunities Master Fund, Ltd. 7.92M 9.99% 7.92M FI Cayman Islands 2024-06-14
2 S.H.N. Financial Investments Ltd. 7.92M 9.99% 7.92M OO Israel 2024-06-14
3 Longboard Capital Advisors, LLC (EIN 86-1150459)   Brett Conrad 652.5K 16.70% 652.5K 652.5K IA, IN Longboard Capital Advisors, LLC – Delaware 2017-07-13
4 91-1150802 561.4K 10.40% 561.4K 561.4K IA Washington 2018-11-07
5 Conrad 210.5K 11.29% 210.5K 210.5K IN – USA 2019-02-14
6 Michael Bryan, Sr. 192.5K 6.10% 192.5K 192.5K IN New Hampshire 2023-03-10

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard Extended Market ETF VXF 0.00% 39.5K 0.05%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
276.0K
Shares disposed
Cash buys
Cash sales
Net activity
+275,972
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-02 Tokman Alexander Y Director / Officer A-Award A Common Stock 26,921 0.00 101,926 D
2026-03-02 Jacroux Richard Officer A-Award A Common Stock 13,461 0.00 33,461 D
2026-01-21 Tokman Alexander Y Director / Officer A-Award A Common Stock 75,000 0.00 75,005 D
2026-01-21 Jacroux Richard Officer A-Award A Common Stock 20,000 0.00 20,000 D
2026-01-21 Harsh Michael Director A-Award A Common Stock 60,324 0.00 65,710 D
2026-01-21 DIGIANDOMENICO ANTHONY Director A-Award A Common Stock 60,324 0.00 136,589 D
2026-01-21 Basenese Lou Director A-Award A Common Stock 60,324 0.00 65,709 D
2025-10-10 DIGIANDOMENICO ANTHONY Director A-Award A Warrants 141,644 6.81 964.6K 141,644 D
2025-06-11 Harsh Michael Director A-Award A Common Stock 5,384 0.00 5,386 D
2025-06-11 DIGIANDOMENICO ANTHONY Director A-Award A Common Stock 5,384 0.00 5,443 D
2025-06-11 Basenese Lou Director A-Award A Common Stock 5,384 0.00 5,385 D
2024-08-27 UBS Group AG 10% Owner P-Purchase A Common Stock 3,715 0.55 2.1K 146,012
2024-08-08 Jacroux Richard 0 0.00 0
2024-01-02 Tokman Alexander Y Director A-Award A Stock Options 600 1.59 954.00 600
2024-01-02 Harsh Michael Director A-Award A Stock Options 600 1.59 954.00 600
2024-01-02 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 600 1.59 954.00 600
2024-01-02 Basenese Lou Director A-Award A Stock Options 600 1.59 954.00 600
2023-05-18 Thornton Michael Milos Officer P-Purchase A Common Stock 15,000 1.65 24.8K 34,139
2023-05-02 DIGIANDOMENICO ANTHONY Director P-Purchase A Common Stock 83,333 1.20 100.0K 102,434
2023-01-30 Tokman Alexander Y Director A-Award A Stock Options 9,621 4.02 38.7K 9,621
2023-01-30 Thornton Michael Milos Officer A-Award A Stock Options 68,066 4.02 273.6K 68,066
2023-01-30 Pestrikova Irina Director / Officer A-Award A Stock Options 8,000 4.02 32.2K 8,000
2023-01-30 Michelon Francois Roger Director / Officer A-Award A Stock Options 69,531 4.02 279.5K 69,531
2023-01-30 Harsh Michael Director A-Award A Stock Options 9,634 4.02 38.7K 9,634
2023-01-30 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 9,621 4.02 38.7K 9,621
2023-01-30 Basenese Lou Director A-Award A Stock Options 6,746 4.02 27.1K 6,746
2022-12-09 Thornton Michael Milos Officer P-Purchase A Common Stock 1,500 3.40 5.1K 19,139
2022-11-23 Tokman Alexander Y Director P-Purchase A Common Stock 10,000 0.17 1.7K 162,857
2022-08-22 Tokman Alexander Y Director P-Purchase A Common Stock 20,000 0.26 5.2K 152,857
2022-08-22 Thornton Michael Milos Officer P-Purchase A Common Stock 20,000 0.27 5.4K 352,775
2022-05-26 Thornton Michael Milos Officer P-Purchase A Common Stock 25,000 0.21 5.3K 332,775
2022-05-18 Thornton Michael Milos Officer P-Purchase A Common Stock 25,000 0.22 5.5K 307,775
2022-05-17 Michelon Francois Roger Officer P-Purchase A Common Stock 5,100 0.19 969.00 97,191
2022-05-16 Tokman Alexander Y Director P-Purchase A Common Stock 100,000 0.20 19.6K 132,857
2022-03-28 Tokman Alexander Y Director A-Award A Stock Options 109,323 0.00 109,323
2022-03-28 Thornton Michael Milos Officer A-Award A Stock Options 698,102 0.00 698,102
2022-03-28 Pestrikova Irina Director / Officer A-Award A Stock Options 41,500 0.00 41,500
2022-03-28 Michelon Francois Roger Officer A-Award A Stock Options 713,132 0.00 713,132
2022-03-28 Maloberti Renaud Bertrand Officer A-Award A Stock Options 186,430 0.00 186,430
2022-03-28 Harsh Michael Director A-Award A Stock Options 109,492 0.00 109,492
2022-03-28 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 109,323 0.00 109,323
2022-03-28 Basenese Lou Director A-Award A Stock Options 74,500 0.00 74,500
2022-01-03 Tokman Alexander Y Director A-Award A Stock Options 12,000 0.74 8.9K 12,000
2022-01-03 Harsh Michael Director A-Award A Stock Options 12,000 0.74 8.9K 12,000
2022-01-03 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 12,000 0.74 8.9K 12,000
2022-01-03 Basenese Lou Director A-Award A Stock Options 12,000 0.74 8.9K 12,000
2021-08-26 Basenese Lou Director S-Sale D Common Stock 5,000 1.85 9.3K 49,068
2021-08-25 Basenese Lou Director S-Sale D Common Stock 45,000 1.83 82.4K 54,068
2021-06-18 Pestrikova Irina Director / Officer D Stock Options 4,000 0.70 2.8K 0
2021-04-07 Thornton Michael Milos Officer S-Sale D Common Stock 15,000 2.53 38.0K 259,960
2021-04-05 Wells David R. Officer A-Award A Stock Options 25,000 2.64 66.0K 25,000
2021-04-05 Tokman Alexander Y Director A-Award A Stock Options 25,000 2.64 66.0K 25,000
2021-04-05 Thornton Michael Milos Officer A-Award A Stock Options 50,000 2.64 132.0K 50,000
2021-04-05 Michelon Francois Roger Director / Officer A-Award A Stock Options 50,000 2.64 132.0K 50,000
2021-04-05 Maloberti Renaud Bertrand Officer A-Award A Stock Options 25,000 2.64 66.0K 25,000
2021-04-05 Harsh Michael Director A-Award A Stock Options 25,000 2.64 66.0K 25,000
2021-04-05 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 25,000 2.64 66.0K 25,000
2021-04-05 Basenese Lou Director A-Award A Stock Options 25,000 2.64 66.0K 25,000
2021-03-29 Thornton Michael Milos Officer S-Sale D Common Stock 18,750 2.37 44.4K 274,960
2021-02-11 Thornton Michael Milos Officer A-Award A Common Stock 22,815 0.00 316,525
2021-01-28 Thornton Michael Milos Officer A-Award A Common Stock 22,815 0.00 316,525
2021-01-13 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 13,696 1.10 15.1K 1,580
2021-01-12 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 6,304 1.05 6.6K 15,276
2021-01-08 Tokman Alexander Y Director S-Sale D Common Stock 10,000 0.90 9.0K 32,857
2021-01-08 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 8,731 0.94 8.2K 21,580
2021-01-06 Wells David R. Officer S-Sale D Common Stock 34,900 0.90 31.4K 80,003
2021-01-06 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 11,269 0.94 10.6K 30,311
2021-01-05 Wells David R. Officer S-Sale D Common Stock 100 0.90 90.00 114,903
2021-01-04 Tokman Alexander Y Director A-Award A Stock Options 12,000 0.80 9.6K 12,000
2021-01-04 Harsh Michael Director A-Award A Stock Options 12,000 0.80 9.6K 12,000
2021-01-04 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 12,000 0.80 9.6K 12,000
2021-01-04 Basenese Lou Director A-Award A Stock Options 12,000 0.80 9.6K 12,000
2020-12-17 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 25,000 0.73 18.3K 41,580
2020-12-04 Michelon Francois Roger Director / Officer S-Sale D Common Stock 71,519 0.83 59.4K 92,091
2020-11-13 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 10,000 0.81 8.1K 66,580
2020-10-22 Basenese Lou Director A-Award A Stock Option (right to buy) 50,000 0.73 36.5K 50,000
2020-10-01 Maloberti Renaud Bertrand Officer S-Sale D Common Stock 10,000 0.72 7.2K 76,580
2020-07-21 DIGIANDOMENICO ANTHONY Director X-InTheMoney D Warrants 100,503 0.87 87.4K 0
2020-07-15 Thornton Michael Milos Officer X-InTheMoney A Common Stock 26,000 0.87 22.6K 293,710
2020-06-23 Wells David R. Officer X-InTheMoney A Common Stock 5,000 0.87 4.4K 115,003
2020-06-23 Michelon Francois Roger Director / Officer X-InTheMoney A Common Stock 2,874 0.87 2.5K 163,610
2020-06-23 Harsh Michael Director X-InTheMoney A Common Stock 5,000 0.87 4.4K 69,243
2020-06-08 Wells David R. Officer C-Conversion D Series A Convertible Preferred Stock 9 0.87 7.61 0
2020-06-08 Thornton Michael Milos Officer C-Conversion D Series A Convertible Preferred Stock 44 0.87 38.04 0
2020-06-08 Michelon Francois Roger Director / Officer C-Conversion D Series A Convertible Preferred Stock 4 0.87 3.80 0
2020-06-08 Harsh Michael Director C-Conversion D Series A Convertible Preferred Stock 10 0.87 8.37 0
2020-06-08 DIGIANDOMENICO ANTHONY Director P-Purchase A Common Stock 5,000 0.92 4.6K 281,509
2020-05-29 Basenese Lou Director P-Purchase A Common Stock 10,000 0.90 9.0K 99,068
2020-05-28 DIGIANDOMENICO ANTHONY Director P-Purchase A Common Stock 5,000 0.90 4.5K 276,509
2020-05-28 Basenese Lou Director P-Purchase A Common Stock 10,000 0.91 9.1K 89,068
2020-05-27 Basenese Lou Director P-Purchase A Common Stock 10,000 0.85 8.5K 79,068
2020-05-26 Basenese Lou Director P-Purchase A Common Stock 10,000 0.82 8.2K 69,068
2020-05-22 DIGIANDOMENICO ANTHONY Director P-Purchase A Common Stock 10,000 0.78 7.8K 252,083
2020-05-21 Basenese Lou Director P-Purchase A Common Stock 10,000 0.71 7.1K 59,068
2020-04-09 Wells David R. Officer A-Award A Common Stock 79,653 0.00 99,653
2020-04-09 Tokman Alexander Y Director A-Award A Common Stock 42,857 0.00 42,857
2020-04-09 Thornton Michael Milos Officer A-Award A Common Stock 96,213 0.00 215,963
2020-04-09 Michelon Francois Roger Director / Officer A-Award A Common Stock 123,064 0.00 155,561
2020-04-09 Maloberti Renaud Bertrand Officer A-Award A Common Stock 86,580 0.00 86,580
2020-04-09 Harsh Michael Director A-Award A Common Stock 42,857 0.00 52,857
2020-04-09 Gambhir Sanjiv Sam Director A-Award A Common Stock 42,857 0.00 42,857
2020-04-09 DIGIANDOMENICO ANTHONY Director A-Award A Common Stock 42,857 0.00 242,083
2020-04-09 Basenese Lou Director A-Award A Common Stock 41,587 0.00 41,587
2020-01-25 Wells David R. Officer A-Award A Stock Options 20,000 1.71 34.2K 20,000
2020-01-25 Maloberti Renaud Bertrand Officer A-Award A Stock Options 20,000 1.71 34.2K 20,000
2020-01-02 Tokman Alexander Y Director A-Award A Stock Options 12,000 1.90 22.8K 12,000
2020-01-02 Harsh Michael Director A-Award A Stock Options 12,000 1.90 22.8K 12,000
2020-01-02 Gambhir Sanjiv Sam Director A-Award A Stock Options 12,000 1.90 22.8K 12,000
2020-01-02 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 12,000 1.90 22.8K 12,000
2019-12-11 Wells David R. Officer A-Award A Series A Convertible Preferred Stock 9 0.87 7.61 9
2019-12-11 Tokman Alexander Y Director A-Award A Stock option (right to buy) 89,585 0.90 80.6K 89,585
2019-12-11 Thornton Michael Milos Officer A-Award A Warrants 50,252 0.87 43.7K 50,252
2019-12-11 Michelon Francois Roger Director / Officer A-Award A Warrants 5,026 0.87 4.4K 5,026
2019-12-11 Maloberti Renaud Bertrand Officer A-Award A Stock option (right to buy) 42,859 0.90 38.6K 42,859
2019-12-11 Harsh Michael Director A-Award A Stock option (right to buy) 89,922 0.90 80.9K 89,922
2019-12-11 Gambhir Sanjiv Sam Director A-Award A Stock option (right to buy) 89,585 0.90 80.6K 89,585
2019-12-11 DIGIANDOMENICO ANTHONY Director A-Award A Common Stock 100,503 0.87 87.4K 199,226
2019-09-27 Wells David R. Officer P-Purchase A Common Stock 10,000 1.18 11.8K 20,000
2019-08-23 Wells David R. Officer P-Purchase A Common Stock 5,000 1.55 7.8K 10,000
2019-08-22 Wells David R. Officer P-Purchase A Common Stock 5,000 1.56 7.8K 5,000
2019-06-10 Harsh Michael Director P-Purchase A Common Stock 500 1.14 570.00 10,000
2019-06-07 Harsh Michael Director P-Purchase A Common Stock 2,800 1.12 3.1K 9,500
2019-06-06 Harsh Michael Director P-Purchase A Common Stock 6,600 1.11 7.3K 6,700
2019-06-05 Harsh Michael Director P-Purchase A Common Stock 100 1.20 120.00 100
2019-05-28 Maloberti Renaud Bertrand Officer A-Award A Stock Options 35,000 1.04 36.4K 35,000
2019-05-16 Thornton Michael Milos Officer P-Purchase A Common Stock 30,000 1.13 33.9K 119,750
2019-05-13 Wells David R. Officer A-Award A Stock Options 56,000 1.38 77.3K 56,000
2019-03-25 Tokman Alexander Y Director A-Award A Stock Options 50,000 3.09 154.5K 50,000
2019-03-25 Harsh Michael Director A-Award A Stock Options 50,000 3.09 154.5K 50,000
2019-03-25 Gambhir Sanjiv Sam Director A-Award A Stock Options 50,000 3.09 154.5K 50,000
2019-03-25 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 50,000 3.09 154.5K 50,000
2018-12-13 Wells David R. Officer A-Award A Stock Options 35,000 2.25 78.8K 35,000
2018-12-13 Thornton Michael Milos Officer A-Award A Stock Options 125,000 2.25 281.3K 125,000
2018-12-13 Michelon Francois Roger Director / Officer A-Award A Stock Options 125,000 2.25 281.3K 125,000
2018-11-13 Wells David R. Officer C-Conversion D Convertible Promissory Note 0 1.68 0
2018-11-13 Thornton Michael Milos Officer C-Conversion D Convertible Promissory Note 0 1.68 0
2018-11-13 Michelon Francois Roger Director / Officer C-Conversion D Convertible Promissory Note 0 1.68 0
2018-11-13 DIGIANDOMENICO ANTHONY Director C-Conversion D Convertible Promissory Note 0 1.68 0
2018-10-24 Longboard Capital Advisors, LLC 10% Owner S-Sale D Common Stock 30,000 4.18 125.3K 299,237
2018-10-23 Longboard Capital Advisors, LLC 10% Owner S-Sale D Common Stock 50,000 4.22 210.9K 329,237
2018-10-22 Longboard Capital Advisors, LLC 10% Owner S-Sale D Common Stock 50,200 4.16 209.1K 379,237
2018-06-28 Wells David R. Officer A-Award A Warrants 2,480 2.52 6.2K 2,480
2018-06-28 Thornton Michael Milos Officer A-Award A Warrants 12,401 2.52 31.3K 12,401
2018-06-28 Michelon Francois Roger Director / Officer A-Award A Warrants 2,480 2.52 6.2K 2,480
2018-06-28 DIGIANDOMENICO ANTHONY Director A-Award A Warrants 24,802 2.52 62.5K 24,802
2018-01-02 Tokman Alexander Y Director A-Award A Stock Options 6,061 4.95 30.0K 6,061
2018-01-02 Harsh Michael Director A-Award A Stock Options 6,061 4.95 30.0K 6,061
2018-01-02 Gambhir Sanjiv Sam Director A-Award A Stock Options 6,061 4.95 30.0K 6,061
2018-01-02 DIGIANDOMENICO ANTHONY Director A-Award A Stock Options 6,061 4.95 30.0K 6,061
2017-07-11 Longboard Capital Advisors, LLC 10% Owner I Warrants 210,538 6.25 1.32M 0
2017-06-09 Thornton Michael Milos Officer A-Award A Stock Options 31,960 4.55 145.4K 31,960
2017-06-09 Michelon Francois Roger Director / Officer A-Award A Stock Options 31,960 4.55 145.4K 31,960
2017-05-12 Wells David R. Officer A-Award A Stock Options 7,000 5.00 35.0K 7,000
2017-05-12 Tokman Alexander Y Director A-Award A Stock Options 12,000 5.00 60.0K 12,000
2017-05-12 Thornton Michael Milos Officer A-Award A Stock Options 313,338 5.00 1.57M 313,338
2017-05-12 Michelon Francois Roger Director / Officer A-Award A Stock Options 307,310 5.00 1.54M 307,310
2017-05-12 Harsh Michael Director A-Award A Stock Options 12,000 5.00 60.0K 12,000
2017-05-12 Gambhir Sanjiv Sam Director A-Award A Stock Options 6,000 5.00 30.0K 6,000
2017-05-12 DIGIANDOMENICO ANTHONY Director C-Conversion A Common Stock 19,426 1.40 27.2K 58,625
2017-05-09 Longboard Capital Advisors, LLC 10% Owner I Common Stock, $0.0001 par value 0 0.00 210,538
2017-05-08 Wells David R. Officer D No securities are beneficially owned 0 0.00 0
2017-05-08 Thornton Michael Milos Officer D Stock Options 29,470 10.01 295.0K 0
2017-05-08 Michelon Francois Roger Director / Officer D Convertible Promissory Note 0 1.40 0
2017-05-08 DIGIANDOMENICO ANTHONY Director D Convertible Promissory Note 0 1.40 0
2016-01-19 Thornton Michael Milos Officer D Warrants to Purchase Common Stock 999 20.02 20.0K 0
2016-01-01 Tokman Alexander Y Director D Stock Options 1,799 10.01 18.0K 0
2016-01-01 Harsh Michael Director D Stock Options 1,799 10.01 18.0K 0
2016-01-01 Gambhir Sanjiv Sam Director D Stock Options 1,799 10.01 18.0K 0
2016-01-01 DIGIANDOMENICO ANTHONY Director D Stock Options 1,799 10.01 18.0K 0
2015-07-07 Tokman Alexander Y Director D Stock Options 3,297 10.01 33.0K 0
2015-07-07 Harsh Michael Director D Stock Options 3,571 10.01 35.7K 0
2015-07-07 Gambhir Sanjiv Sam Director D Stock Options 3,297 10.01 33.0K 0
2015-07-07 DIGIANDOMENICO ANTHONY Director D Stock Options 3,297 10.01 33.0K 0
2015-05-29 Longboard Capital Advisors, LLC 10% Owner I Warrants 12,488 20.03 250.1K 0
2013-09-04 DIGIANDOMENICO ANTHONY Director D Warrants to Purchase Common Stock 999 20.02 20.0K 0

Executive team

Top executives
Shares Outstanding
752.6K

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2023 Francois Michelon Chief Executive Officer 387.9K 258.3K 587.00 646.8K 39.94%
2 2023 Michael Thornton Chief Technology Officer 278.9K 252.7K 392.00 532.0K 47.51%
3 2023 Irina Pestrikova Senior Director, Finance 185.0K 29.7K 214.7K 13.84%
4 2022 Francois Michelon Chief Executive Officer 423.0K 212.6K 587.00 636.2K 33.42%
5 2022 Michael Thornton Chief Technology Officer 301.3K 208.1K 392.00 509.8K 40.83%
6 2022 Renaud Maloberti Former Chief Commercial Officer 296.0K 55.6K 365.00 351.9K 15.79%
7 2022 Irina Pestrikova Senior Director, Finance 175.0K 12.4K 187.3K 6.61%
8 2021 Francois Michelon Chief Executive Officer 374.0K 812.4K 137.6K 587.00 1.32M 61.33%
9 2021 Michael Thornton Chief Technology Officer 286.2K 812.4K 72.6K 392.00 1.17M 69.34%
10 2021 Renaud Maloberti Former Chief Commercial Officer 263.3K 608.8K 58.3K 365.00 930.7K 65.41%
11 2021 Renaud Maloberti Former Chief Commercial Officer 263.3K 608.8K 58.3K 930.3K 65.44%
12 2020 Francois Michelon Chief Executive Officer 373.4K 133.3K 587.00 507.3K 0.00%
13 2020 Michael Thornton Chief Technology Officer 280.8K 82.5K 392.00 363.8K 0.00%
14 2020 David Wells Chief Financial Officer 244.1K 30.5K 54.9K 1.5K 331.0K 9.21%
15 2019 Francois Michelon Chief Executive Officer 352.8K 514.6K 111.9K 979.3K 52.55%
16 2019 Michael Thornton Chief Technology Officer 265.3K 484.3K 61.5K 811.0K 59.71%
17 2019 David Wells Chief Financial Officer 179.5K 189.9K 48.3K 417.7K 45.47%
18 2018 Francois Michelon Chief Executive Officer 339.6K 103.5K 244.8K 687.9K 35.58%
19 2018 Michael Thornton Chief Technology Officer 256.3K 54.6K 244.8K 555.6K 44.05%
20 2018 David R. Wells Chief Financial Officer 111.8K 20.1K 78.8K 210.6K 37.39%
21 2018 David Wells Chief Financial Officer 111.8K 20.1K 56.2K 188.1K 29.88%
22 2017 Francois Michelon Chief Executive Officer 347.5K 93.3K 1.38M 1.82M 75.77%
23 2017 Michael Thornton Chief Technology Officer 281.6K 44.2K 1.40M 1.73M 81.15%
24 2017 David R. Wells Chief Financial Officer 92.0K 10.0K 94.2K 72.9K 269.1K 62.09%
25 2016 Francois Michelon Chief Executive Officer 262.2K 262.2K 0.00%
26 2016 Michael Thornton Chief Technology Officer 218.1K 218.1K 0.00%
27 2016 David R. Wells Chief Financial Officer 60.0K 60.0K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-10-28 DEFA14A
2025-10-28 DEF 14A
2025-10-17 PRE 14A
2024-09-17 DEFA14A
2024-09-16 DEF 14A
2024-09-06 PRE 14A
2024-07-17 DEFA14A
2024-06-25 DEFA14A
2024-06-25 DEF 14A
2024-06-12 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-15 S-8
2026-05-15 10-Q
2026-04-21 8-K
2026-03-31 8-K
2026-03-31 10-K
2026-03-25 8-K
2026-03-04 4
2026-03-04 4
2026-01-23 4
2026-01-23 4

Executive team

NameTitleCompensationGender
Alexander Y. Tokman Chief Executive Officer & Chairman 300.0K male
Richard Jacroux Chief Financial Officer & Secretary 133.4K male
Idan Steinberg Head of Engineering male
Jonathan Behr Co-Founder
Scott Sober Head of Operations male
Ziad Rouag Head of Regulatory & Clinical Affairs male
ESG Rating
A-
MEDICAL - DIAGNOSTICS & RESEARCH
Rank: 1 out of 64
2026
E (Environmental)
53.1 / 61.3
Company / Sector avg.
S (Social)
79.4 / 65.4
Company / Sector avg.
G (Governance)
74.8 / 64.9
Company / Sector avg.
ESG Total
69.1 / 63.8
Company / Sector avg.
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits